Understanding factors affecting low-level HIV viremia in West Africa
Official title: Use of Pharmacoepidemiology to Understand Predictors and Impact of Low-level Viremia in Persons with HIV in West Africa
Funded at Nigerian Institute of Medical Research · NIH-11084518 · Data updated 2026-11-12
This study is looking at why some people with HIV in West Africa have low levels of the virus and how we can help them stick to their treatment better, so they can stay healthy and keep the virus under control.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nigerian Institute of Medical Research NIH-funded |
| Lab location | 1 site (Lagos, Nigeria) |
| Project start | July 15, 2023 |
| Project end | April 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $64,980 |
| NIH project number | 5K43TW012648-03 |
| Project ID | NIH-11084518 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals aged 21 and older living with HIV in West Africa, particularly those experiencing low-level viremia.
✕Less likely to help
Patients who are not living with HIV or those outside the age range of 21 and older may not benefit from this research.
What this research studies
This research focuses on identifying and analyzing the factors that contribute to low-level viremia in individuals living with HIV in West Africa. By utilizing pharmacoepidemiology and experimental pharmacology, the project aims to improve strategies for achieving sustained viral suppression in HIV treatment. The study will involve both retrospective and prospective cohorts, examining adherence to antiretroviral therapy through various innovative measures. Patients may be monitored through pharmacy refill records and specialized tests to assess their treatment adherence.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for individuals living with HIV, enhancing their health outcomes and quality of life.
How similar studies have gone: Previous research in similar areas has shown promise in understanding HIV treatment adherence and its impact on viral suppression, indicating that this approach has potential for success.
Where this research is happening
-
Nigerian Institute of Medical Research
Lagos, Nigeria Active
Researchers
- Principal investigator: Herbertson, Ebiere Clara — Nigerian Institute of Medical Research
- Study coordinator: Herbertson, Ebiere Clara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.